Identification of mouse colony-forming endothelial progenitor cells for postnatal neovascularization: A novel insight highlighted by new mouse colony-forming assay

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Tsukada, Shizu ^a   Kwon, Sang Mo ^b   Matsuda, Takenori ^c   Jung, Seok Yun ^b   Lee, Jun Hee ^b   Lee, Sang Hun ^b   Masuda, Haruchika ^a   Asahara, Takayuki ^a,c  

^a TOKAI UNIVERSITY   (Japan)

^b Pusan National University School of Medicine   (South Korea)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; CADHERIN; LEUKOCYTE ANTIGEN; NOS3 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CAPILLARY DENSITY; CELL ADHESION; CELL ASSAY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CELL TYPE; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HINDLIMB; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEG BLOOD FLOW; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; ISCHEMIA; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL;

MURINAE;

ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CADHERINS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENDOTHELIAL PROGENITOR CELLS; HINDLIMB; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84876533695     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt168     Document Type: Article

References (29)

1. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076
2. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM, Circ Res 1999 85 221 228 10.1161/01.RES.85.3.221 10436164
3. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Naiyer AJ, Jo DY, Ahn J, Mohle R, Peichev M, Lam G, Silverstein RL, Moore MA, Rafii S, Blood 1999 94 4011 4019 10590044
4. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Isner JM, Asahara T, J Clin Invest 1999 103 1231 1236 10.1172/JCI6889 10225965
5. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S, Lyden D, Nat Med 2003 9 702 712 10.1038/nm0603-702 12778169
6. Circulating endothelial cells after transplantation. Gunsilius E, Petzer AL, Duba HC, Kahler CM, Gastl G, Lancet 2001 357 1449 1450 11360955
7. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, Oh BH, Choi YS, Walsh K, Park YB, Circulation 2003 108 2918 2925 10.1161/01.CIR.0000097001.79750.78 14568896
8. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T, J Clin Invest 2000 105 1527 1536 10.1172/JCI8296 10841511
9. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T, Proc Natl Acad Sci USA 2000 97 3422 3427 10.1073/pnas.97.7.3422 10725398
10. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T, Circulation 2003 107 461 468 10.1161/01.CIR.0000046450.89986.50 12551872
11. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T, Circulation 2001 103 634 637 10.1161/01.CIR.103.5.634 11156872
12. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ, Diabetes 2004 53 195 199 14693715
13. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC, Circulation 2002 106 2781 2786 10.1161/01.CIR.0000039526.42991.93 12451003
14. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T, N Engl J Med 2003 348 593 600 10.1056/NEJMoa022287 12584367
15. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S, Circ Res 2001 89 1 7 10.1161/hh1301.093953 11440984
16. Endothelial progenitor cells for postnatal vasculogenesis. Asahara T, Kawamoto A, Am J Physiol Cell Physiol 2004 287 572 579 10.1152/ajpcell.00330. 2003 15308462
17. Origins of circulating endothelial cells and endothelial outgrowth from blood. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP, J Clin Invest 2000 105 71 77 10.1172/JCI8071 10619863
18. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC, Blood 2004 104 2752 2760 10.1182/blood-2004-04-1396 15226175
19. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA, Blood 2007 109 1801 1809 10.1182/blood-2006-08-043471 17053059
20. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB, Arterioscler Thromb Vasc Biol 2004 24 288 293 14699017
21. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D, Stem Cells 2007 25 1746 1752 10.1634/stemcells.2006-0833 17395771
22. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM, Embo J 1999 18 3964 3972 10.1093/emboj/18.14.3964 10406801
23. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S, Nat Med 2003 9 1370 1376 10.1038/nm948 14556003
24. Mouse model of angiogenesis. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM, Am J Pathol 1998 152 1667 1679 9626071
25. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Drake CJ, Fleming PA, Blood 2000 95 1671 1679 10688823
26. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T, Nat Med 1999 5 434 438 10.1038/7434 10202935
27. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC, Nat Med 2004 10 858 864 10.1038/nm1075 15235597
28. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, Agostini C, Avogaro A, Diabetologia 2006 49 3075 3084 10.1007/s00125-006-0401-6 17072586
29. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M, Blood 2004 104 3472 3482 10.1182/blood-2003-12-4423 15284120